Bioasis Technologies Inc.

BTI:TSX.V

Bioasis Technologies Inc. is a Vancouver-based biopharmaceutical company engaged in the development and commercialization of technologies for the diagnosis and treatment of central nervous system (CNS) disorders. Valued at more than US$98B, the CNS market segment is the second-largest category in the pharmaceutical industry and is growing at approximately 8% per annum. The World Health Organization has declared that CNS disorders represent the major medical challenge of the 21st century.

streetwise book logo Streetwise Company Fact Sheet

2024/5/21 15:56:24

(BTI:TSX.V)